aminolevulinic acid has been researched along with Leishmaniasis, Cutaneous in 18 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cutaneous leishmaniasis is one of the most common travel dermatoses in Germany, which can be acquired not only in Africa, Asia or the American continent, but also in southern European countries." | 1.72 | [Successful treatment of Old World cutaneous leishmaniasis with red or green light photodynamic therapy]. ( Balakirski, G; Burmann, SN; Hofmann, SC; Kreuter, A; Lehmann, P; Oellig, F; Paschos, A, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 5 (27.78) | 2.80 |
| Authors | Studies |
|---|---|
| Burmann, SN | 1 |
| Oellig, F | 1 |
| Paschos, A | 1 |
| Hofmann, SC | 1 |
| Lehmann, P | 1 |
| Kreuter, A | 1 |
| Balakirski, G | 1 |
| Liu, L | 1 |
| He, Y | 1 |
| Chang, J | 1 |
| Khan, K | 1 |
| Khan, AU | 1 |
| Khan, A | 1 |
| Khan, M | 1 |
| Ahmad, I | 1 |
| Sharma, R | 1 |
| Viana, SM | 1 |
| Ng, DKP | 1 |
| Kolli, BK | 1 |
| Chang, KP | 1 |
| de Oliveira, CI | 1 |
| Hobelsberger, S | 1 |
| Krauß, MP | 1 |
| Bogdan, C | 1 |
| Aschoff, R | 1 |
| Slape, DR | 1 |
| Kim, EN | 1 |
| Weller, P | 1 |
| Gupta, M | 1 |
| Johansen, MB | 1 |
| Jemec, GBE | 1 |
| Fabricius, S | 1 |
| Souza, DM | 1 |
| Alves, PM | 1 |
| Silva, ML | 1 |
| Paulino, TP | 1 |
| Coraspe, HO | 1 |
| Mendonça, MM | 1 |
| Ribeiro, BM | 1 |
| da Silva, MV | 1 |
| Rodrigues Júnior, V | 1 |
| Rodrigues, DB | 1 |
| van der Snoek, EM | 1 |
| Robinson, DJ | 1 |
| van Hellemond, JJ | 1 |
| Neumann, HA | 1 |
| Kluger, N | 1 |
| Girard, C | 1 |
| Debu, A | 1 |
| Guillot, B | 1 |
| Evangelou, G | 1 |
| Krasagakis, K | 1 |
| Giannikaki, E | 1 |
| Kruger-Krasagakis, S | 1 |
| Tosca, A | 1 |
| Lee, Y | 1 |
| Baron, ED | 1 |
| Enk, CD | 2 |
| Fritsch, C | 2 |
| Jonas, F | 1 |
| Nasereddin, A | 1 |
| Ingber, A | 1 |
| Jaffe, CL | 1 |
| Ruzicka, T | 3 |
| Gardlo, K | 2 |
| Horska, Z | 1 |
| Rauch, L | 1 |
| Megahed, M | 1 |
| Hanneken, S | 1 |
| Neumann, NJ | 1 |
| Kosaka, S | 2 |
| Akilov, OE | 2 |
| O'Riordan, K | 2 |
| Hasan, T | 2 |
| Ghaffarifar, F | 1 |
| Jorjani, O | 1 |
| Mirshams, M | 1 |
| Miranbaygi, MH | 1 |
| Hosseini, ZK | 1 |
3 reviews available for aminolevulinic acid and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
Efficacy of photodynamic therapy in cutaneous leishmaniasis: A systematic review.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Child; Child, Preschool; Humans; In | 2023 |
A review of photodynamic therapy in cutaneous leishmaniasis.
Topics: Aminolevulinic Acid; Humans; Leishmaniasis, Cutaneous; Photochemotherapy; Photosensitizing Agents; P | 2008 |
Photodynamic therapy: current evidence and applications in dermatology.
Topics: Acne Vulgaris; Aminolevulinic Acid; Bowen's Disease; Candidiasis; Carcinoma, Basal Cell; Humans; Ker | 2011 |
2 trials available for aminolevulinic acid and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
Fractionated illumination improves the treatment outcomes of photodynamic therapy for high grade cutaneous leishmaniasis.
Topics: Aminolevulinic Acid; Female; Humans; Leishmaniasis, Cutaneous; Male; Pain Measurement; Pakistan; Pho | 2020 |
Photodynamic therapy as a new treatment of cutaneous leishmaniasis.
Topics: Aminolevulinic Acid; Drug Administration Schedule; Drug Monitoring; Humans; Hyperpigmentation; Infla | 2006 |
13 other studies available for aminolevulinic acid and Leishmaniasis, Cutaneous
| Article | Year |
|---|---|
[Successful treatment of Old World cutaneous leishmaniasis with red or green light photodynamic therapy].
Topics: Aminolevulinic Acid; Humans; Leishmaniasis, Cutaneous; Photochemotherapy; Photosensitizing Agents | 2022 |
Photodynamic inactivation of Leishmania braziliensis doubly sensitized with uroporphyrin and diamino-phthalocyanine activates effector functions of macrophages in vitro.
Topics: Aminolevulinic Acid; Animals; Animals, Genetically Modified; Female; Humans; Immunity, Innate; In Vi | 2020 |
[Successful treatment of cutaneous leishmaniasis with simulated daylight photodynamic therapy].
Topics: Aminolevulinic Acid; Child, Preschool; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Male; P | 2022 |
Leishmania tropica successfully treated with photodynamic therapy.
Topics: Adult; Aminolevulinic Acid; Facial Dermatoses; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; | 2019 |
Effective treatment with photodynamic therapy of cutaneous leishmaniasis: A case report.
Topics: Adolescent; Aminolevulinic Acid; Follow-Up Studies; Humans; Leishmaniasis, Cutaneous; Male; Photoche | 2019 |
5-ALA-mediated photodynamic therapy reduces the parasite load in mice infected with Leishmania braziliensis.
Topics: Aminolevulinic Acid; Animals; Cytokines; Interferon-gamma; Leishmania braziliensis; Leishmaniasis, C | 2017 |
Efficacy of photodynamic therapy in cutaneous leishmaniasis: a "hidden" local heat effect?
Topics: Aminolevulinic Acid; Hot Temperature; Humans; Leishmaniasis, Cutaneous; Light; Photochemotherapy | 2010 |
Successful treatment of cutaneous leishmaniasis with intralesional aminolevulinic acid photodynamic therapy.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Humans; Leishmaniasis, Cutaneous; Male; Photoche | 2011 |
Treatment of cutaneous leishmaniasis with photodynamic therapy.
Topics: Adult; Aminolevulinic Acid; Female; Humans; Leishmaniasis, Cutaneous; Male; Middle Aged; Photochemot | 2003 |
Treatment of cutaneous leishmaniasis by photodynamic therapy.
Topics: Adult; Amebicides; Aminolevulinic Acid; Humans; Leishmaniasis, Cutaneous; Male; Ointments; Paromomyc | 2003 |
[Photodynamic therapy of cutaneous leishmaniasis. A promising new therapeutic modality].
Topics: Adult; Aminolevulinic Acid; Diagnosis, Differential; Humans; Leishmaniasis, Cutaneous; Male; Photoch | 2004 |
A mechanistic study of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis.
Topics: Aminolevulinic Acid; Animals; Cell Line, Transformed; Leishmania major; Leishmaniasis, Cutaneous; Ma | 2007 |
Parasiticidal effect of delta-aminolevulinic acid-based photodynamic therapy for cutaneous leishmaniasis is indirect and mediated through the killing of the host cells.
Topics: Aminolevulinic Acid; Animals; Cell Line, Transformed; Disease Models, Animal; Ear, External; Interle | 2007 |